{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:20:07Z","timestamp":1780478407439,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:00:00Z","timestamp":1757721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008750","name":"Shanghai Municipal Hospital Development Center","doi-asserted-by":"publisher","award":["2020CR3004A"],"award-info":[{"award-number":["2020CR3004A"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82090054"],"award-info":[{"award-number":["82090054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2023YFC2413700"],"award-info":[{"award-number":["2023YFC2413700"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jconrel.2025.114161","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T06:49:07Z","timestamp":1756882147000},"page":"114161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Fluorescent Probes Targeting Acyl-CoA Synthetase Long-Chain Family Member 4 for Intraoperative Imaging of Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"387","author":[{"given":"Jinpeng","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanru","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunwei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jconrel.2025.114161_bb0005","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114161_bb0010","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/SLA.0000000000001556","article-title":"A review and update of treatment options and controversies in the management of hepatocellular carcinoma","volume":"263","author":"Dhir","year":"2016","journal-title":"Ann. Surg."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114161_bb0015","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/JS9.0000000000000204","article-title":"Significance of anatomical resection and resection margin status in patients with HBV-related hepatocellular carcinoma and microvascular invasion: a multicenter propensity score-matched study","volume":"109","author":"Zhang","year":"2023","journal-title":"Int. J. Surg."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114161_bb0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2019.08.032","article-title":"Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis","volume":"72","author":"Berardi","year":"2020","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114161_bb0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/SLA.0000000000002112","article-title":"Oncological outcomes after robotic proctectomy for rectal cancer: analysis of a prospective database","volume":"267","author":"Sammour","year":"2018","journal-title":"Ann. Surg."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114161_bb0030","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.7150\/thno.9899","article-title":"Intraoperative imaging-guided cancer surgery: from current fluorescence molecular imaging methods to future multi-modality imaging technology","volume":"4","author":"Chi","year":"2014","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114161_bb0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/SLA.0000000000004718","article-title":"Consensus guidelines for the use of fluorescence imaging in hepatobiliary surgery","volume":"274","author":"Wang","year":"2021","journal-title":"Ann. Surg."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114161_bb0040","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/cncr.24291","article-title":"Real-time identification of liver cancers by using indocyanine green fluorescent imaging","volume":"115","author":"Ishizawa","year":"2009","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jconrel.2025.114161_bb0045","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1245\/s10434-013-3360-4","article-title":"Mechanistic background and clinical applications of indocyanine green fluorescence imaging of hepatocellular carcinoma","volume":"21","author":"Ishizawa","year":"2014","journal-title":"Ann. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114161_bb0050","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1021\/acs.chemrev.3c00776","article-title":"Fluorescent probes for disease diagnosis","volume":"124","author":"Wang","year":"2024","journal-title":"Chem. Rev."},{"issue":"20","key":"10.1016\/j.jconrel.2025.114161_bb0055","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1039\/D3CS00032J","article-title":"Glycosidase-targeting small molecules for biological and therapeutic applications","volume":"52","author":"Kim","year":"2023","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114161_bb0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0016-5085(03)00689-9","article-title":"Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma","volume":"125","author":"Capurro","year":"2003","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114161_bb0065","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1084\/jem.20180870","article-title":"Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer","volume":"216","author":"Gong","year":"2019","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114161_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001875","article-title":"Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in hepatocellular carcinoma","volume":"9","author":"Sun","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114161_bb0075","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd4519","article-title":"Principles in the design of ligand-targeted cancer therapeutics and imaging agents","volume":"14","author":"Srinivasarao","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114161_bb0080","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1158\/0008-5472.CAN-22-1532","article-title":"Proteomic profiling of extracellular matrix components from patient metastases identifies consistently elevated proteins for developing nanobodies that target primary tumors and metastases","volume":"83","author":"Jailkhani","year":"2023","journal-title":"Cancer Res. (Chicago, Ill.)"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114161_bb0085","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41557-023-01328-5","article-title":"DNAzyme-based faithful probing and pulldown to identify candidate biomarkers of low abundance","volume":"16","author":"Hu","year":"2024","journal-title":"Nat. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114161_bb0090","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.1038\/s41467-023-44255-2","article-title":"Proteomics-driven noninvasive screening of circulating serum protein panels for the early diagnosis of hepatocellular carcinoma","volume":"14","author":"Xing","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114161_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-020-0226-z","article-title":"ACSL4 promotes hepatocellular carcinoma progression via c-Myc stability mediated by ERK\/FBW7\/c-Myc axis","volume":"9","author":"Chen","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.jconrel.2025.114161_bb0100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canlet.2020.12.019","article-title":"ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc\/SREBP1 pathway","volume":"502","author":"Chen","year":"2021","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114161_bb0105","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrc.2016.89","article-title":"The multifaceted roles of fatty acid synthesis in cancer","volume":"16","author":"Rohrig","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.114161_bb0110","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.12659\/MSM.906639","article-title":"Overexpression of acyl-CoA ligase 4 (ACSL4) in patients with hepatocellular carcinoma and its prognosis","volume":"23","author":"Sun","year":"2017","journal-title":"Med. Sci. Monitor"},{"issue":"6","key":"10.1016\/j.jconrel.2025.114161_bb0115","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s00018-020-03679-5","article-title":"New inhibitor targeting acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis","volume":"78","author":"Castillo","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"13","key":"10.1016\/j.jconrel.2025.114161_bb0120","doi-asserted-by":"crossref","first-page":"eadk1200","DOI":"10.1126\/sciadv.adk1200","article-title":"Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases","volume":"10","author":"Huang","year":"2024","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114161_bb0125","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41568-024-00690-x","article-title":"Cancer therapy with antibodies","volume":"24","author":"Paul","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"20","key":"10.1016\/j.jconrel.2025.114161_bb0130","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1039\/D0BM00943A","article-title":"The development of a Glypican-3-specific binding peptide using in vivo and in vitro two-step phage display screening for the PET imaging of hepatocellular carcinoma","volume":"8","author":"Qin","year":"2020","journal-title":"Biomater. Sci. UK"},{"issue":"9","key":"10.1016\/j.jconrel.2025.114161_bb0135","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1136\/gutjnl-2021-325180","article-title":"Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours","volume":"71","author":"Huang","year":"2022","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.jconrel.2025.114161_bb0140","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.biotechadv.2013.04.004","article-title":"In vivo phage display\u2014a discovery tool in molecular biomedicine","volume":"31","author":"B\u00e1b\u00ed\u010dkov\u00e1","year":"2013","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2025.114161_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.962124","article-title":"In vivo phage display: a promising selection strategy for the improvement of antibody targeting and drug delivery properties","volume":"13","author":"Andr\u00e9","year":"2022","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114161_bb0150","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2019.08.052","article-title":"Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma","volume":"179","author":"Gao","year":"2019","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.jconrel.2025.114161_bb0155","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1073\/pnas.94.7.2880","article-title":"A novel arachidonate-preferring acyl-CoA synthetase is present in steroidogenic cells of the rat adrenal, ovary, and testis","volume":"94","author":"Kang","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.jconrel.2025.114161_bb0160","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1021\/acschembio.5b00245","article-title":"Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death","volume":"10","author":"Dixon","year":"2015","journal-title":"ACS Chem. Biol."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114161_bb0165","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","article-title":"Ferroptosis: machinery and regulation","volume":"17","author":"Chen","year":"2021","journal-title":"Autophagy"},{"issue":"8","key":"10.1016\/j.jconrel.2025.114161_bb0170","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41419-022-05137-5","article-title":"ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression","volume":"13","author":"Grube","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114161_bb0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13046-021-02208-x","article-title":"Epigenetic regulation of ferroptosis via ETS1\/miR-23a-3p\/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma","volume":"41","author":"Lu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114161_bb0180","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41401-020-0439-x","article-title":"ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma","volume":"42","author":"Feng","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114161_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.706","article-title":"Role of ACSL4 in modulating farnesoid X receptor expression and M2 macrophage polarization in HBV-induced hepatocellular carcinoma","volume":"5","author":"Chen","year":"2024","journal-title":"Medcomm"},{"issue":"23","key":"10.1016\/j.jconrel.2025.114161_bb0190","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1158\/0008-5472.CAN-24-0832","article-title":"Extracellular vesicle-packaged ACSL4 induces hepatocyte senescence to promote hepatocellular carcinoma progression","volume":"84","author":"Hou","year":"2024","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114161_bb0195","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/liv.15839","article-title":"Impact of ACSL4 on the prognosis of hepatocellular carcinoma: association with cancer-associated fibroblasts and the tumour immune microenvironment","volume":"44","author":"Toshida","year":"2024","journal-title":"Liver Int."},{"key":"10.1016\/j.jconrel.2025.114161_bb0200","doi-asserted-by":"crossref","first-page":"45913","DOI":"10.1038\/srep45913","article-title":"Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues","volume":"7","author":"Gao","year":"2017","journal-title":"Sci. Rep. UK"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114161_bb0210","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200219","article-title":"Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases","volume":"40","author":"Ndiaye","year":"2020","journal-title":"Biosci. Rep."},{"issue":"6220","key":"10.1016\/j.jconrel.2025.114161_bb0215","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.jconrel.2025.114161_bb0225","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1091\/mbc.e10-08-0683","article-title":"A guide to simple and informative binding assays","volume":"21","author":"Pollard","year":"2010","journal-title":"Mol. Biol. Cell"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114161_bb0230","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1021\/jacs.8b09198","article-title":"Multivalent ligand binding to cell membrane antigens: defining the interplay of affinity, valency, and expression density","volume":"141","author":"Csizmar","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114161_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.201600335","article-title":"Identification of a glypican-3-binding peptide for in vivo non-invasive human hepatocellular carcinoma detection","volume":"17","author":"Qin","year":"2017","journal-title":"Macromol. Biosci."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114161_bb0240","first-page":"7422","article-title":"Anti-GPC3 single-chain scFv antibody acts as an agent for radio-immunoimaging in diagnosing hepatocellular carcinoma","volume":"11","author":"Guan","year":"2019","journal-title":"Am. J. Transl. Res."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114161_bb0245","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/j.apsb.2021.06.010","article-title":"Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression","volume":"11","author":"Li","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.jconrel.2025.114161_bb0250","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231519","article-title":"PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy","volume":"221","author":"Wang","year":"2024","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114161_bb0255","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2967\/jnumed.111.101527","article-title":"Tumor targeting using affibody molecules: interplay of affinity, target expression level, and binding site composition","volume":"53","author":"Tolmachev","year":"2012","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2025.114161_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103850","article-title":"Image-guided surgery with a new tumour-targeting probe improves the identification of positive margins","volume":"76","author":"Goto","year":"2022","journal-title":"Ebiomedicine"},{"key":"10.1016\/j.jconrel.2025.114161_bb0265","doi-asserted-by":"crossref","first-page":"1367040","DOI":"10.3389\/fimmu.2024.1367040","article-title":"PD-L1 targeted peptide demonstrates potent antitumor and immunomodulatory activity in cancer immunotherapy","volume":"15","author":"Liang","year":"2024","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.jconrel.2025.114161_bb0270","doi-asserted-by":"crossref","first-page":"8516","DOI":"10.1021\/acs.analchem.5c00530","article-title":"Signal-to-noise ratio imaging and real-time sharpening of tumor boundaries for image-guided Cancer surgery","volume":"97","author":"Wang","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2025.114161_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.875688","article-title":"Tumor-background ratio is an effective method to identify tumors and false-positive nodules in indocyanine-green navigation surgery for pediatric liver cancer","volume":"10","author":"Feng","year":"2022","journal-title":"Front. Pediatr."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925007734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925007734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:55:29Z","timestamp":1780476929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925007734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":53,"alternative-id":["S0168365925007734"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114161","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluorescent Probes Targeting Acyl-CoA Synthetase Long-Chain Family Member 4 for Intraoperative Imaging of Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114161"}}